AKT1 and neoplasm: Likewise, tumor-suppressive miR-199a/b inhibits ROCK1/MLC and PI3K/Akt pathways via targeting the Rho-associated coiled-coil kinase 1 (ROCK1) in HBV-HCC, and its low expression is also associated with poor overall survival (27).